Soligenix (SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach

Soligenix (NASDAQ: SNGX) is emphasizing the strategic importance of patient-centric drug development, as outlined by CEO ...

Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach

By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader Soligenix (NASDAQ: ...
News-Medical.Net

New mechanism disables antibiotic resistance and cross-protection in bacteria

A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance ...
Everyday Health on MSN

When is a sore throat considered chronic?

A chronic sore throat lasts for more than 10 days and doesn't go away on its own. While most sore throats are caused by a ...

ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of the HoT study (Menopausal Hormone Therapy for Women Living with HIV, also known as ...
College of Natural Sciences

Researchers Disable Antimicrobial Resistance in Cystic Fibrosis-Associated Bacteria

A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance ...